Ann Oncol,2011 . 22 Suppl 6:vi25-30 .Arobase:A phase Ⅲ trial of exemestane(Exe)and bevacizumab(BEV)as maintenance therapy in patients(pts)with metastatic breast cancer(MBC)treated in first line with paclitaxel(P)and BEV--A Gineco study .Gloyeske,N . C .,D ......